The concerns of Xieli: Customer-centric, with high quality products, high quality service, to meet user needs, to surpass user expectations;

The slogan of Xieli: Quality first, risk control, patient protection, safe production

According to the development needs and overall plan of the company, under the leadership of the company's chairman Zhang Qiang, under the overall guidance and organization of the company's quality department, from July 12, 2023 to July 16, 2023, the SiChuan Medical Products Administration according to the company's declaration needs, conducted a 5-day GMP compliance inspection to our 3 products Artificialcow-bezoar, Cystine, Letrozole, in strict accordance with the requirements of the "Good Manufacturing Practice (2010 Revision)" and the appendix. During the inspection, the experts of the inspection team of the SiChuan Medical Products Administration put forward a lot of valuable and reasonable suggestions and some corrective actions requirements. 

Continuous improvement is the eternal goal of the Company. For the valuable opinions and corrective actions requirements put forward by the inspection team experts, the Company has combined the actual situation, organized full participation, and carried out corresponding improvements and correction in strict accordance with the requirements. On August 15, 2023, we obtained the notice of inspection results issued by the SiChuan Medical Products Administration that the drug GMP on-site inspection results were in line with the "Good Manufacturing Practice (2010 Revision)" and the requirements of the appendix.

Through the GMP compliance inspection, Xieli is more believing, drugs must be centered on people's health, must unswervingly continue to improve, optimize the production process, and constantly improve the quality management system to ensure product quality, Xieli pharmaceutical will move forward in continuously, healthy and steady way.